Background: The T 2 w sequence is a standard component of a prostate MRI examination; however, it is time-consuming, requiring multiple signal averages to achieve acceptable image quality. Purpose/Hypothesis: To determine whether a denoised, single-average T 2 sequence (T 2 -R) is noninferior to the standard multiaverage T 2 sequence (T 2 -S) in terms of lesion detection and PI-RADS score assessment. Study Type: Retrospective. Population: A total of 45 males (age range 60-75 years) who underwent clinically indicated prostate MRI examinations, 21 of whom had pathologically proven prostate cancer. Field Strength/Sequence: A 3 T; T 2 w FSE, DWI with ADC maps, and dynamic contrast-enhanced images with color-coded perfusion maps. T 2 -R images were created from the raw data utilizing a single "average" with iterative denoising. Assessment: Nine readers randomly assessed complete exams including T 2 -R and T 2 -S images in separate sessions. PI-RADS version 2.1 was used. All readers then compared the T 2 -R and T 2 -S images side by side to evaluate subjective preference. An additional detailed image quality assessment was performed by three senior level readers. Statistical Tests: Generalized linear mixed effects models for differences in lesion detection, image quality features, and overall preference between T 2 -R and T 2 -S sequences. Intraclass correlation coefficients (ICC) were used to assess reader agreement for all comparisons. A significance threshold of P = 0.05 was used for all statistical tests. Results: There was no significant difference between sequences regarding identification of lesions with PI-RADS ≥3 (P = 0.10) or PI-RADS score (P = 0.77). Reader agreement was excellent for lesion identification (ICC = 0.84). There was no significant overall preference between the two sequences regarding image quality (P = 0.07, 95% CI: [À0.23, 0.01]). Reader agreement was good regarding sequence preference (ICC = 0.62). Data Conclusion: Use of single-average, denoised T 2 -weighted images was noninferior in prostate lesion detection or PI-RADS scoring when compared to standard multiaverage T 2 -weighted images. Evidence Level: 3. Technical Efficacy: Stage 3.